Send Orders for Reprints to reprints@benthamscience.ae Effectiveness of a Standardized and Specific Follow-Up in Memory Centers in Patients with Alzheimer's Disease

Archive ouverte

Rouch, Laure | Cestac, Philippe | Cool, Charlène | Helmer, Catherine | Dartigues, Jean-François | Berr, Claudine | Rouaud, Olivier | Vellas, Bruno | Andrieu, Sandrine

Edité par CCSD ; Bentham Science Publishers -

International audience. Objectives: To compare the 4-year survival, institutionalization, cognitive and functional decline of Alzheimer's patients with specific follow-up in memory centers versus usual care. Design: Four year longitudinal follow-up. Settings: The French Network of memory centers in Alzheimer's disease (REAL-FR study) and The French population-based study (3C study). Participants: 728 patients aged ≥ 65, living at home, meeting criteria for probable Alzheimer's disease and having Mini Mental State Examination (MMSE) scores between 10 and 26 at baseline were included. Measurements: Cox proportional hazards models were performed to test the effectiveness of a specific follow-up in memory centers (REAL-FR study) versus usual care (3C study) on the 4-year survival and institutionalization. Linear mixed models were used to assess cognitive and functional decline in both groups. Results: After adjustment for confounding factors, the 4-year survival did not differ significantly between patients followed-up in memory centers and those who had recourse to usual care (usual care: Hazard Ratio adjusted (HRa) = 0.87, 95% confidence interval (CI) 0.53-1.43, p=0.59). Patients with a specific follow-up in memory centers had a higher risk of being institutionalized (usual care: HRa = 0.24, 95% CI 0.12-0.48, p<0.001). They also exhibited a significant greater cognitive and functional decline over time. Conclusion: Our findings failed to demonstrate any potential benefits of a specific follow-up in memory centers on clinically meaningful outcomes in the natural history of Alzheimer's disease. Recourse to care in memory centers may have been the consequence of a faster dementia progression and a greater burden of Alzheimer's disease, all leading to detrimental consequences on various prognostic outcomes.

Suggestions

Du même auteur

Biomarkers of mitochondrial dysfunction and inflammaging in older adults and blood pressure variability

Archive ouverte | Bencivenga, Leonardo | CCSD

International audience. Most physiopathological mechanisms underlying blood pressure variability (BPV) are implicated in aging. Vascular aging is associated with chronic low-grade inflammation occurring in late life...

Healthcare Costs Associated with Potentially Inappropriate Medication Prescribing Detected by Computer Algorithm Among Older Patients

Archive ouverte | Pagès, Arnaud | CCSD

International audience. IntroductionPotentially inappropriate medication prescribing (PIP) among older patients is associated with an increased risk of adverse events and hospitalization, and sometimes increased hea...

Blood pressure, antihypertensive drugs, and incident frailty. Blood pressure, antihypertensive drugs, and incident frailty: The Multidomain Alzheimer Preventive Trial (MAPT)

Archive ouverte | Rouch, Laure | CCSD

International audience. Objectives: To examine the association of (1) high and low blood pressure (BP) and (2) antihypertensive (AH) drug use with incident frailty.Study design: We conducted a secondary analysis of ...

Chargement des enrichissements...